(Today's bear raid creates a great entry point. No chance of a R/S as annual meeting filings do not mention and XOMA can easily transfer to NASDAQ Capital Market without being over one dollar).
"The current technical condition for XOMA is strong and the chart pattern suggests that upward momentum should continue.
The stock has outperformed the market over the last 50 trading days when compared to the S&P 500. The MACD-LT is confirming that the
intermediate-term trend is bullish. Upside momentum, as measured by the 9-day RSI indicator is very strong. Over the last 50 trading sessions, there
has been more volume on up days than on down days indicating that XOMA is under accumulation, which is a bullish condition. The stock is trading
above a rising 50-day moving average. This validates the strong technical condition for XOMA."
The large AH block trades are either dark pool trades that have a time lag in getting reported or order imbalances that get settled.
1) Their in-house programs;
2) Partnership with Novo Nordisk
3) Partnership with Novartis;
4) Holds $1,000,000 in Agenus (AGEN) stock
Sentiment: Strong Buy
The recent heavy options buying of Feb 18 $1.00 Calls virtually guaranteed that the manipulators would keep the Calls out of the money. Monday should see a nice rebound.
The hatchet piece in San Francisco Business News conveniently ignores the fact that two major pharmas thought enough of XOMA compounds to do deals. It s just a matter of time before XOMA sells Gevo and/or is bought out.
I bought 4K shares AH on Friday because of the news. The potential is incredible as stem cell therapy has only been tried in less than optimum cases and has worked. Getting off a respirator is huge and saves big money in hospital costs. As stem cells are implanted in better candidates the results should be even better. The potential worldwide market is huge!
I added 4000 shares after hours. Just a modest but sustained improvement is HUGE. The health care savings would be tremendous. Many successful drugs are only incremental improvements, but reap billions in sales.
The truth of the matter is that ETRM knew that they did have the resources to properly launch Vbloc, dangled "partnership discussions" for a year, and failed to deliver.
Fact check: We DO NOT HAVE THE MONEY to market Vbloc. The money raised will be mostly eaten up by salaries, including $1 million to the three new guys who are hired guns who will fail, just like in a Sergio Leone western.
I sold all my holdings at .16 (equal to 2.40 post-split) right after Gladney's clueless spiel. I have seen many micro caps in freefall, but NEVER to the extent with a company with an FDA approved product. I don't know if GOD exists, but I'm beginning to think that Lucifer, disguised as snake Lea, does exist!
That snake Lea has a cure for nausea: don't buy one share of ETRM, but collect a rich six figure salary, while engineering death spiral financing schemes.
There has been virtually no increase in LIKES or FOLLOWERS on those two paramount social medias; also, the info is mainly old. A buyout is the only avenue that makes any sense.
Not only that, he gets an ADDITIONAL 12monhts FULL SALARY. These guys have no shame.
A $27,000 procedure with moderate weight loss results DOES NOT FLY OFF THE SHELVES! What part of that do you not understand?
The Vbloc implant price should be reduced to $7000; with $12,000 for the surgeon and facility the total is about $19,000. Insurers and outfits like Kaiser would probably bite. $27,000 is way too much for a niche procedure. Folks, this is not a new cancer, aids, or Hep C drug. Insurers won't get on board until momentum is built, and you can't do that with a soak the rich strategy.